Literature DB >> 11969278

Direct coronary stenting versus stenting with balloon pre-dilation: immediate and follow-up results of a multicentre, prospective, randomized study. The DISCO trial. DIrect Stenting of COronary Arteries.

L Martínez-Elbal1, J M Ruiz-Nodar, J Zueco, J R López-Minguez, J Moreu, I Calvo, J A Ramirez, M Alonso, N Vazquez, R Lezaun, C Rodriguez.   

Abstract

AIMS: To assess the safety of direct coronary stenting, its influence on costs, duration of the procedure, radiation exposure, clinical outcome and angiographic restenosis. METHODS AND
RESULTS: We randomized 416 patients (446 lesions) to direct stent implant or stent implant following balloon pre-dilation. Patients >75 years old, heavily calcified lesions, bifurcations, total occlusions, left main lesions and very tortuous vessels were excluded. Direct stenting was successful in 217/224 lesions (96.8%). No single loss or embolization of the stent occurred. All stents in the group with pre-dilation were effectively deployed. The immediate post-procedure angiographic results were similar with both techniques. Fluoroscopy and procedural time were significantly lower in direct stenting (6.4+/-0.3 and 21+/-0.9 min) than in pre-dilated stenting (9.1+/-0.4 and 27.5+/-1.1 min) (P>0.001). Major adverse cardiac events during hospitalization were one in direct and four in pre-dilated stenting (P=0.05) but there were no significant differences at follow-ups at 1, 6 and 12 months between the two groups. Angiographic reevaluation at 6 months was performed in 94% of the cases. Restenosis rate was 16.5% in direct stenting and 14.3% in pre-dilated stenting (P=ns).
CONCLUSIONS: Direct stenting is as safe as pre-dilated stenting in selected coronary lesions. Acute angiographic results are similar but procedural costs, duration of the procedure and radiation exposure are lower in direct stenting. Overall success rate, mid-term clinical outcome and restenosis are similar with both techniques. Copyright 2002 The European Society of Cardiology.

Entities:  

Mesh:

Year:  2002        PMID: 11969278     DOI: 10.1053/euhj.2001.2893

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

1.  Managing a complication after direct stenting: removal of a maldeployed stent with rotational atherectomy.

Authors:  M Herzum; R Cosmeleata; B Maisch
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

2.  Percutaneous coronary intervention: recommendations for good practice and training.

Authors:  K D Dawkins; T Gershlick; M de Belder; A Chauhan; G Venn; P Schofield; D Smith; J Watkins; H H Gray
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

Review 3.  In stent restenosis: bane of the stent era.

Authors:  A K Mitra; D K Agrawal
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

4.  In vivo evaluation of a novel dexamethasone-heparin-double-coated stent for inhibition of artery restenosis and thrombosis.

Authors:  Qing-Kui Guo; Zhi-Qian Lu; Jin-Ye Wang; Tao Li
Journal:  J Mater Sci Mater Med       Date:  2011-05-10       Impact factor: 3.896

5.  Is coronary stent deployment and remodeling affected by predilatation? An intravascular ultrasound randomized study Stenting with or without predilation: an IVUS study.

Authors:  Jacques Boschat; Hervé Le Breton; P Commeau; Bernard Huret; Marc Bedossa; Martine Gilard
Journal:  Int J Cardiovasc Imaging       Date:  2002-12       Impact factor: 2.357

6.  Direct coronary stenting in reducing radiation and radiocontrast consumption.

Authors:  Jasmin Caluk; Enes Osmanovic; Fahir Barakovic; Zumreta Kusljugic; Ibrahim Terzic; Selma Caluk; Amela Sofic
Journal:  Radiol Oncol       Date:  2010-09-09       Impact factor: 2.991

7.  Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention.

Authors:  Guo-Hua Zheng; Jian-Ping Liu; Nissi S Wang; Hai-Ying Chen; Jian-Feng Chu
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-16       Impact factor: 2.629

8.  In-hospital and mid-term adverse clinical outcomes of a direct stenting strategy versus stenting after pre-dilatation for the treatment of coronary artery lesions.

Authors:  M Alidoosti; M Salarifar; S E Kassaian; A M Zeinali; M S Fathollahi; M R Dehkordi
Journal:  Cardiovasc J Afr       Date:  2008 Nov-Dec       Impact factor: 1.167

9.  What is better for predilatation in bioresorbable vascular scaffold implantation: a non-compliant or a compliant balloon?

Authors:  Erdem Özel; Ahmet Taştan; Ali Öztürk; Emin Evren Özcan; Samet Uyar; Ömer Şenarslan
Journal:  Anatol J Cardiol       Date:  2015-06-18       Impact factor: 1.596

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.